Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

(2014) Yan-Li Li et al.   BMC CANCER

Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma

(2014) Shogo Kumagai et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

(2014) Volker Heinemann et al.   LANCET ONCOLOGY

Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma

(2014) Luis F. Porrata et al.   LEUKEMIA & LYMPHOMA

Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study

(2014) Pingping Hu et al.   PLoS One

Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis

(2014) Sally Temraz et al.   BMC Urology

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients

(2014) Peng Xue et al.   Cancer Medicine

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer

(2013) M Stotz et al.   BRITISH JOURNAL OF CANCER

Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow

(2013) Shankar J. Evani et al.   FASEB JOURNAL

The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages

(2012) Y. W. Koh et al.   ONCOLOGIST

Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer

(2011) Joji Kitayama et al.   BMC CANCER

Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy

(2011) N. Cézé et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

(2010) Hideaki Shimada et al.   Gastric Cancer

Inflammation and Colon Cancer

(2010) Janoš Terzić et al.   GASTROENTEROLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

(2008) Axel Grothey et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE